Scott Sheehan

Scott Sheehan is an Executive Director of Due Diligence at Eli Lilly and Company, bringing 25 years of experience in the pharmaceutical industry. Previously, they held various senior roles at Eli Lilly, including Senior Director of the Diligence Team and Chief Scientific Officer for Global Molecular Design & Enabling Technologies. Scott earned a Ph.D. in Organic Chemistry from Emory University and completed a post-doctoral fellowship at Harvard University. They also contributed to research at Harvard and have held multiple leadership positions across drug discovery and technology.